In Australia in the last five years, an estimated 6066 women per year have undergone hysterectomies to treat fibroid-related diseases, while just 145 women each year have undergone a uterine artery embolisation, or UAE.
The procedure can effectively treat the majority of bleeding uterine fibroids. Each year, thousands of Australian women undergo invasive and life-altering hysterectomies to treat debilitating pain and blood loss caused by uterine fibroids. But there’s another option: a minimally invasive, pin-hole procedure that treats the symptoms, yet leaves the uterus intact.
Professor Warren Clements, interventional radiologist and head of the UAE service at The Alfred, said despite the proven safety and efficacy of the procedure – which was developed in the 1990s – it is simply not provided as an option to many women, something he urgently wants to change.
“Fibroids are highly prevalent in society and women need access to a range of different treatments so that they can choose what is the best for them,” Prof Clements said in an interview with Australian Health Journal.
“Every year, many women have a hysterectomy who would be suitable for a non-surgical alternative. UAE is an amazing non-surgical treatment and allows women to keep their uterus if they want to.”
The procedure is all done through a single pinhole incision, whereas a hysterectomy requires open surgery. It involves using low-dose x-rays and contrast dye to guide catheters through the arteries towards fibroids in the uterus. A medication is used to block the blood supply to the fibroids, which causes them to shrink. The procedure takes about half an hour, is done under ‘twilight’ sedation, and only requires one overnight recovery stay.
”Many women aren’t aware that this is a very minor procedure compared to hysterectomy,” Prof Clements said. “Women can resume normal activities the following day. The recovery is short, and most women can go back to work within a week. More than 90 per cent of women with heavy periods will have significant improvement in their symptoms after UAE.”
Professor Warren Clements, is also Honorary Researcher – Interventional Radiology, National Trauma Research Institute, Professor, Interventional Radiologist (IR) and the Head of Fluoroscopy in the Department of Radiology at Alfred Health. He is also a Fellow of the Royal Australian and New Zealand College of Radiologists (RANZCR).
Credit: Alfred Health
-
Report gives insights to clinical trial activity in Australia
Established in 2024, Bellberry is a Adelaide-based national, not-for-profit organisation that provides streamlined scientific and ethical reviews of human research. It is the 2025 winner of the Championing Health Award in the Telstra Best of Business Awards.
Australian Health Journal spoke with Bellberry Limited CEO, Kylie Sproston on the organisation and the findings in activity documented in the Clinical Trial Activity Report (CTAR) 2024.
-
Access and productivity outcomes with radiology technology in Western Sydney
In Western Sydney, there is currently significant growth accompanied by a notable need for cardiovascular support due to the prevalence of related diseases. It is estimated that the population in this area will reach 6 million by 2041.
With this population growth, there is also a pressing shortage of healthcare professionals in Australia, particularly in the field of radiology, where there are not enough radiographers, sonographers, MRI technicians, and nuclear medicine technicians.
-
Substantial increase in allied health funding for veterans through DVA
The Australian Federal 2026–27 Budget included several significant announcements relating to allied health services for veterans, largely tied to the Government’s response to recommendations from the Royal Commission into Defence and Veteran Suicide.
